FEB 23, 2020 7:28 AM PST

New discovery could help preterm babies breathe easy

WRITTEN BY: Tara Fernandez

Babies born more than three weeks before full term are met with complicated and often life-threatening health challenges. Most notably, these tiny preterm babies often experience respiratory distress, which manifests as labored breathing and a heightened risk of developing lung infections. Even if preterm babies are able to fight against respiratory problems in their first weeks of life, they are not out of the woods. Research has shown that these babies tend to be affected by chronic, long-term respiratory illnesses as toddlers and young children.

Hitesh Deshmukh, MD, Ph.D., a neonatologist based at Cincinnati Children's, led a research team that investigated the intricate immunological pathways underlying these acute and chronic respiratory issues faced by preterm babies.

The study, published in the journal Immunology, detailed how preterm babies are born before their Type 3 innate lymphoid cells have a chance to develop. These cells represent a key component of the immune system that is critical to protecting mucous membranes, such as the lining of the lungs. The absence of these cells means that these vulnerable babies are unable to mount a robust immune response against microorganisms they breathe in.

In follow-up studies, the scientists aim to design strategies to promote the development of Type 3 innate lymphoid cells in preterm babies, hypothesizing that this will shield them against pathogenic infections and tissue inflammation.

 

 

"This study gives us important new information that helps us develop new and cost-effective methods to boost innate lung immunity in preterm babies. This could help them develop lifelong pulmonary resistance to respiratory infections,'' said Deshmukh.

The World Health Organization estimates that 15 million babies are born preterm annually. Though certain maternal complications such as diabetes and high blood pressure can contribute to an increased risk of preterm birth, more often than not, there is no clear cause of why these babies are born early.

Along with these respiratory health obstacles, preterm babies often have drastically altered gut microbiomes as a result of intensive antibiotic treatment regimens. The authors are hopeful that a combination of commensal bacteria administration and hormone therapy can assist these young babies to survive their first months of life and defend them against future infections.

 

Sources: Immunity, Medical Xpress News.

 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 24, 2020
Drug Discovery & Development
FDA Grants Emergency Approval for Blood Plasma to Treat COVID-19
AUG 24, 2020
FDA Grants Emergency Approval for Blood Plasma to Treat COVID-19
The US Food and Drug Agency (FDA) has given emergency approval for expanded use of antibody-rich blood plasma to help th ...
SEP 16, 2020
Immunology
Depression, but Not Anxiety, Causes Inflammation and Metabolic Imbalances
SEP 16, 2020
Depression, but Not Anxiety, Causes Inflammation and Metabolic Imbalances
Scientists have discovered that depressed individuals show higher levels of inflammation as well as elevated fat concent ...
OCT 21, 2020
Drug Discovery & Development
Experimental Vaccine Shows Promise in Halting Alzheimer's
OCT 21, 2020
Experimental Vaccine Shows Promise in Halting Alzheimer's
In a preclinical study, researchers from the Univerity of South Florida have found that a vaccine that targets neurotoxi ...
NOV 06, 2020
Drug Discovery & Development
New Vaccine Shows Promise for Herpes
NOV 06, 2020
New Vaccine Shows Promise for Herpes
The World Health Organization estimates that over 500 million people have Herpes Simplex Virus Type 2 (HSV-2), a sexuall ...
NOV 12, 2020
Immunology
The Enzyme That Keeps Viruses In Stealth Mode
NOV 12, 2020
The Enzyme That Keeps Viruses In Stealth Mode
Some viral infections just don’t go away. The hepatitis C virus, for instance, can result in life-long chronic inf ...
NOV 10, 2020
Neuroscience
Nanoparticles Pass the Blood-Brain Barrier in Zebrafish
NOV 10, 2020
Nanoparticles Pass the Blood-Brain Barrier in Zebrafish
Video:  Explains the challenges of delivering medicine to the brain, and possibly tools to pass the blood-brain bar ...
Loading Comments...